The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-Methyl-N-Nitrosourea-Induced rat mammary carcinogenesis

Cancer Prevention Research

Volumn 3, Issue 3, 2010, Pages 322-330

  Manni, Andrea ^a   Xu, Haifang ^a   Washington, Sharlene ^a   Aliaga, Cesar ^a   Cooper, Timothy ^a   Richie Jr , John P ^a   Bruggeman, Richard ^a   Prokopczyk, Bogdan ^a   Calcagnotto, Ana ^a   Trushin, Neil ^a   Mauger, David ^a   Verderame, Michael F ^a   El Bayoumy, Karam ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; METHYLNITROSOUREA; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ALKYLATING AGENTS; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; CELL PROLIFERATION; FATTY ACIDS; FEMALE; FISH OILS; LIVER; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY; TAMOXIFEN;

EID: 77949732089     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0173     Document Type: Article

References (35)

1. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-88.
2. Vogel VG, Costantino JP, Wickerham DL, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006;295:2727-41.
3. Osborne CK, Shou J, Massarweh S, Schiff R. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res 2005;11:865-70s.
4. Johnston SR. Combinations of endocrine and biological agents: present status of therapeutic and presurgical investigations. Clin Cancer Res 2005;11:889-99s.
5. Thompson HJ, Singh M, McGinley J. Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea. J Mammary Gland Biol Neoplasia 2000;5:201-10.
6. Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-α, -β, and -γ, liver X receptor-β, and retinoid X receptor-α. Toxicol Sci 2006;92:476-89.
7. Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 1999;83:217-44.
8. Lupton J, Chapkin R. Chemopreventive effects of omega-3 fatty acids. In: Kelloff GJ, Hawk E, Segman CC, editors. Cancer chemoprevention vol. 1: promising cancer chemopreventive agents. Totowa (NJ): The Human Press, Inc.; 2004, p. 591-608.
9. Calviello G, Serini S, Piccioni E, Pessina G. Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. Nutr Cancer 2009;61:287-301.
10. Bonofiglio D, Gabriele S, Aquila S, et al. Estrogen receptor α binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor γ signaling in breast cancer cells. Clin Cancer Res 2005;11:6139-47.
11. Wang X, Kilgore MW. Signal cross-talk between estrogen receptor α and β and the peroxisome proliferator-activated receptor γ1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol Cell Endocrinol 2002;194:123-33.
12. Chung SS, Kim M, Youn BS, et al. Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor γ in human skeletal muscle cells. Mol Cell Biol 2009;29:20-30.
13. Yu X, Shao XG, Sun H, et al. Activation of cerebral peroxisome proliferator-activated receptors γ exerts neuroprotection by inhibiting oxidative stress following pilocarpine-induced status epilepticus. Brain Res 2008;1200:146-58.
14. Komatsu W, Ishihara K, Murata M, Saito H, Shinohara K. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-γ plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic Biol Med 2003;34:1006-16.
15. Sneddon AA, Wu HC, Farquharson A, et al. Regulation of seleno-protein GPx4 expression and activity in human endothelial cells by fatty acids, cytokines and antioxidants. Atherosclerosis 2003;171:57-65.
16. Sarsilmaz M, Songur A, Ozyurt H, et al. Potential role of dietary omega-3 essential fatty acids on some oxidant/antioxidant parameters in rats' corpus striatum. Prostaglandins Leukot Essent Fatty Acids 2003;69:253-9.
17. Ruxton CH, Reed SC, Simpson MJ, Millington KJ. The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet 2007;20:275-85.
18. Gottardis MM, Jordan VC. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res 1987;47:4020-4.
19. Goodman DG, Maronpot RR, Newberne PM, Popp JA, Squire RA. Proliferative and selected other lesions in the liver of rats. Guides for toxicologic pathology. pp. 1-24Washington (DC): Society for Toxicologic Pathology; 1994.
20. Manni A, Washington S, Hu X, et al. Effects of polyamine synthesis inhibitors on primary tumor features and metastatic capacity of human breast cancer cells. Clin Exp Metastasis 2005;22:255-63.
21. Richie JP, Jr., Skowronski L, Abraham P, Leutzinger Y. Blood glutathione concentrations in a large-scale human study. Clin Chem 1996;42:64-70.
22. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986;27:114-20.
23. Wallen WJ, Belanger MP, Wittnich C. Sex hormones and the selective estrogen receptor modulator tamoxifen modulate weekly body weights and food intakes in adolescent and adult rats. J Nutr 2001;131:2351-7.
24. Wallen WJ, Belanger MP, Wittnich C. Body weight and food intake profiles are modulated by sex hormones and tamoxifen in chronically hypertensive rats. J Nutr 2002;132:2246-50.
25. McCormick DL, Moon RC. Retinoid-tamoxifen interaction in mammary cancer chemoprevention. Carcinogenesis 1986;7:193-6.
26. Lopez M, Lelliott CJ, Tovar S, et al. Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes 2006;55:1327-36.
27. Wade GN, Heller HW. Tamoxifen mimics the effects of estradiol on food intake, body weight, and body composition in rats. Am J Physiol 1993;264:R1219-23.
28. Abou-el-Ela SH, Prasse KW, Farrell RL, Carroll RW, Wade AE, Bunce OR. Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets. Cancer Res 1989;49:1434-40.
29. Harman D. Free radical theory of aging: effect of the amount and degree of unsaturation of dietary rat on mortality rate. Journal of Gerontology 1971;26:451-7.
30. Hopkins GJ, Kennedy TG, Carroll KK. Polyunsaturated fatty acids as promoters of mammary carcinogenesis induced in Sprague-Dawley rats by 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 1981;66:517-22.
31. Deschner EE, Lytle JS, Wong G, Ruperto JF, Newmark HL. The effect of dietary omega-3 fatty acids (fish oil) on azoxymethanol-induced focal areas of dysplasia and colon tumor incidence. Cancer 1990;66:2350-6.
32. Cohen LA, Chen-Backlund JY, Sepkovic DW, Sugie S. Effect of varying proportions of dietary menhaden and corn oil on experimental rat mammary tumor promotion. Lipids 1993;28:449-56.
33. Wei N, Wang B, Zhang QY, et al. Effects of different dietary fatty acids on the fatty acid compositions and the expression of lipid metabolic-related genes in mammary tumor tissues of rats. Nutr Cancer 2008;60:810-25.
34. Wasserman L, Flatt SW, Natarajan L, et al. Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors. Int J Obes Relat Metab Disord 2004;28:49-56.
35. Powles T, Eeles R, Ashley S, et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 1998;352:98-101.